Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Beroni Group's share price for the quarter that ended in Jun. 2024 was $0.82. Beroni Group's Shares Outstanding (EOP) for the quarter that ended in Jun. 2024 was 23.05 Mil. Therefore, Beroni Group's market cap for the quarter that ended in Jun. 2024 was $18.90 Mil.
Beroni Group's quarterly market cap
declined
from Jun. 2023 ($197.46 Mil) to Dec. 2023 ($192.93 Mil) and
declined
from Dec. 2023 ($192.93 Mil) to Jun. 2024 ($18.90 Mil).
Beroni Group's annual market cap
declined
from Dec. 2021 ($155.54 Mil) to Dec. 2022 ($122.62 Mil) but then
increased
from Dec. 2022 ($122.62 Mil) to Dec. 2023 ($192.93 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Beroni Group's Enterprise Value for Today is $-0.44 Mil.
Beroni Group (OTCPK:BNIGF) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Beroni Group Market Cap Related Terms
Beroni Group Market Cap Historical Data
* Premium members only.
The historical data trend for Beroni Group's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Beroni Group's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Beroni Group Market Cap vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Beroni Group's Market Cap distribution charts can be found below:
* The bar in red indicates where Beroni Group's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Beroni Group's Market Cap for the fiscal year that ended in Dec. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Beroni Group (BNIGF) has a Market Cap of $0.18 Mil as of Jul. 29, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Beroni Group and its competitors.
Is Beroni Group's Market Cap too high?
Beroni Group's current Market Cap is $0.18 Mil. The Drug Manufacturers industry median Market Cap is 214.03. Beroni Group's value of $0.18 Mil is 99.9% below this industry median. Overall, Beroni Group has a GF Score™ of 4/100, reflecting its overall financial health beyond just this single metric.
How does Beroni Group's Market Cap compare to PNXP and CRYM?
Beroni Group's Market Cap of $0.18 Mil can be compared against companies in the Drug Manufacturers industry. The industry median Market Cap is 214.03. Beroni Group's value of $0.18 Mil is 99.9% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Drug Manufacturers company?
The median Market Cap among Drug Manufacturers companies is 214.03, based on 1,024 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Beroni Group's current Market Cap of $0.18 Mil is 99.9% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Beroni Group and its competitors. For the Drug Manufacturers industry, the median Market Cap is 214.03 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Beroni Group's current Market Cap is $0.18 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Beroni Group stock overvalued right now?
Beroni Group (BNIGF) has a current Market Cap of $0.18 Mil. The current Market Cap is $0.18 Mil and 99.9% below the Drug Manufacturers industry median of 214.03. Beroni Group's overall GF Score™ is 4/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Beroni Group (BNIGF), the current Market Cap is $0.18 Mil as of Jul. 29, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Beroni Group Ltd is an Australia based company engaged in the sales of smoking control product (NicoBloc), air purifier, water filter, healthcare products and supplements, cell therapies, stem-cell based cosmetics and viral diagnostic kits and also investing in the research and development of oncology drugs and therapies. It has organized its business into four core business areas: cell therapies, developing new anticancer drugs, an e-commerce platform for pharmaceutical and healthcare products, and detection & diagnosis of infectious diseases. Geographically, the company operates in China.
4GF Score
Get the complete analysis for BNIGF
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BNIGF has been successfully added to your 
